Wednesday, March 29, 2023
USA Mirror
  • Login
  • U.S
  • Politics
  • Business
  • Entertainment
    • TV
  • Sports
  • Lifestyle
  • World
  • Health
  • Science
No Result
View All Result
  • U.S
  • Politics
  • Business
  • Entertainment
    • TV
  • Sports
  • Lifestyle
  • World
  • Health
  • Science
No Result
View All Result
USA Mirror
No Result
View All Result
Home U.S

COVID: AstraZeneca says US data for vaccine approval is very big

Abhishek Verma by Abhishek Verma
May 1, 2021
in U.S
0 0
0
COVID: AstraZeneca says US data for vaccine approval is very big
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

AstraZeneca is working as fast as possible to compile data on its COVID to apply for US approval. But the data set is vast, executives said on Friday, as the drugmaker face delays to its submission. 

Mene Pangalos is the executive vice-president of BioPharmacuticals R&D at AstraZeneca. He said there’s a lot more data than just a phase III study. Hence, they are working as fast they can to pull it all together.

RELATED POSTS

US’ Supreme Court takes the side of college athletes in opposition to NCAA

US’ Supreme Court blocks the child slavery complaint against the chocolate firms

Chief executive Pascal Soriot said nothing was wrong with the data in a briefing following the first-quarter results. However, the dataset was very big. 

However, the company said it planned to apply for US approval in the coming weeks. That is a delay from March when the company said it would submit the data in the coming weeks. 

Soriot said the company still expected to hit the output of 200 million doses of the vaccine this month. 

Shipments are increasing of the vaccine jabs as the manufacturing is improving, Sariot said in the briefing. He further added that they never overpromised, and we communicated what we thought was possible at the time. 

AstraZeneca has said it would not make any profit from the shot during the pandemic. For the first time reporting its financial data of distribution and sales of vaccine, it developed with Oxford University. 

The pharmaceutical giant was amid the leaders in the global race to develop a COVID vaccine. It is cheap and transportable shot was hailed as a milestone in the fight against COVID against the crisis. But since has faced a series of setbacks. 

The US with a chance of a vaccine diplomacy

The US handling of the COVID pandemic has had loads of lapses, but vaccine production isn’t one. The Biden administration has plenty of jabs, and now it is sharing some of that premium with other countries. 

The decision to ship as many possible doses of the AstraZeneca vaccine arises at a critical moment. With neighbours, Mexico and Canada, remaining to struggle and India faces a biting surge with new variants of the infections. 

It allows the Biden presidency to engage in vaccine diplomacy. Using the shipments to compel other countries to follow suit and induce goodwill might help other US foreign policy priorities. 

 

ShareTweetPin
Abhishek Verma

Abhishek Verma

A geeky fan of videogames, football, books, and entrepreneurship!

Related Posts

US’ Supreme Court takes the side of college athletes in opposition to NCAA

US’ Supreme Court takes the side of college athletes in opposition to NCAA

by Abhishek Verma
June 30, 2021
0

The US supreme court has governed in support of student-athletes. They were in a reparation row with the NCAA (National...

US’ Supreme Court blocks the child slavery complaint against the chocolate firms

US’ Supreme Court blocks the child slavery complaint against the chocolate firms

by Abhishek Verma
June 19, 2021
0

The Supreme court passed judgement on Nestle and Cargill. The supreme told that the two firms cant be sued for...

US Daredevil dies while attempting to break the record of longest ramp jump

US Daredevil dies while attempting to break the record of longest ramp jump

by Abhishek Verma
June 19, 2021
0

The daredevil named Alex Harvill died in Washington while striving to break the longest motorcycle ramp jump record. The biker...

US’ COVID death rate has crossed 600,000 during the sluggish rate of vaccinations

US’ COVID death rate has crossed 600,000 during the sluggish rate of vaccinations

by Abhishek Verma
June 16, 2021
0

The count of Americans who has died from the COVID-19 has reached above 600,012 and is still increasing. This is...

G7 leaders to divulge the globally implied anti-covidaction plan

G7 leaders to divulge the globally implied anti-covidaction plan

by Abhishek Verma
June 14, 2021
0

All the G7 leaders are to consign to using all their potential and resources to ensure relief from the pandemic....

Next Post
Johnny Crawford, ‘The Rifleman’ actor dies aged 75

Johnny Crawford, 'The Rifleman' actor dies aged 75

Amazon’s profits more than doubled to $8.2 billion

Amazon's profits more than doubled to $8.2 billion

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Categories

  • Business
  • Entertainment
  • Health
  • Lifestyle
  • Misc
  • Politics
  • Science
  • Sports
  • TV
  • U.S
  • World

Site Links

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Contact

© 2022 USAMirror.com

No Result
View All Result
  • U.S
  • Politics
  • Business
  • Entertainment
    • TV
  • Sports
  • Lifestyle
  • World
  • Health
  • Science

© 2022 USAMirror.com

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In